Extended Data Fig. 3: Pathogenic germline variant prevalence by ancestry and stage. | Nature Medicine

Extended Data Fig. 3: Pathogenic germline variant prevalence by ancestry and stage.

From: Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Extended Data Fig. 3

a, Distribution of genetically inferred ancestry across the overall cohort (left) and by germline mutated genes. Asterisks denote enrichment of ASJ-EUR ancestry by Fisher’s exact test (q < 0.05). b, Distribution of clinical stage at diagnosis across the overall cohort (left) and by germline mutated genes. Asterisks denote chi-squared test (q < 0.05).

Back to article page